Kontigo Care AB (KONT) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Sep 24

INTEREST(9M) At SEK 0.13 MM has Grown at inf%
OPERATING CASH FLOW(Y) Lowest at SEK 1.98 MM
RAW MATERIAL COST(Y) Grown by 53.32% (YoY)

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 65 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.27

Return on Equity

-2.74%

Price to Book

1.26

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-27.8%

6 Months

-32.65%

1 Year

-18.69%

2 Years

-45.96%

3 Years

-65.94%

4 Years

-69.92%

5 Years

-48.58%

Kontigo Care AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.50%

EBIT Growth (5y)

-2.25%

EBIT to Interest (avg)

0.27

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.81

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

4.44%

ROE (avg)

2.72%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.27

EV to EBIT

-28.56

EV to EBITDA

14.21

EV to Capital Employed

1.37

EV to Sales

1.72

PEG Ratio

Dividend Yield

ROCE (Latest)

-4.79%

ROE (Latest)

-3.37%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.41% vs -6.58% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -133.33% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.00",
          "val2": "7.10",
          "chgp": "-1.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "0.90",
          "chgp": "-88.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-0.60",
          "chgp": "-133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-193.20%",
          "val2": "-79.30%",
          "chgp": "-11.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.50% vs 1.76% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 300.00% vs -93.10% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.20",
          "val2": "28.90",
          "chgp": "4.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.50",
          "val2": "1.20",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.80",
          "val2": "0.20",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.90%",
          "val2": "1.80%",
          "chgp": "2.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

7.00

7.10

-1.41%

Operating Profit (PBDIT) excl Other Income

0.10

0.90

-88.89%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.40

-0.60

-133.33%

Operating Profit Margin (Excl OI)

-193.20%

-79.30%

-11.39%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.41% vs -6.58% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -133.33% vs 0.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

30.20

28.90

4.50%

Operating Profit (PBDIT) excl Other Income

1.50

1.20

25.00%

Interest

0.40

Exceptional Items

0.00

Consolidate Net Profit

0.80

0.20

300.00%

Operating Profit Margin (Excl OI)

28.90%

1.80%

2.71%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.50% vs 1.76% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 300.00% vs -93.10% in Dec 2023

All Annual Results

Company CV

About Kontigo Care AB

Kontigo Care AB

Pharmaceuticals & Biotechnology

Kontigo Care AB is a Sweden-based company, which is primarily focused on advanced medical equipment industry. The Company operates as a provider of mobile solutions for the treatment of alcoholism. The Company develops TripleA which is a system of care for the treatment of alcoholism. The system consists of a wireless breathalyzer, an application and a health care portal. The portal creates patient care plan and shares it with health care provider. On the basis of this plan, the patient receives information about scheduled sobriety test. Test results are then sent back to the health care provider who can monitor the patient's sobriety every day. The Company operates domestically on the territory of Sweden.

Company Coordinates

Company Details

Pavel Snickares Grand 12 , UPPSALA None : 753 20

Tel: 46 18 4108880

https://www.kontigocare.com/

Registrar Details